Survival Analysis of 478 Hospitalized Patients with Prostate Cancer
10.11735/j.issn.1004-0242.2025.06.A008
- VernacularTitle:前列腺癌医院登记病例478例生存率分析
- Author:
Jun XU
1
;
Haizhen CHEN
;
Lingling LU
;
Bo CAI
;
Hong XU
;
Yuexia GAO
;
Jianguo CHEN
Author Information
1. 南通大学公共卫生学院,江苏南通 226019;启东市人民医院/启东肝癌防治研究所/南通大学附属启东医院,江苏启东 226200
- Publication Type:Journal Article
- Keywords:
prostate cancer;
follow-up;
survival rate;
cancer registration;
Jiangsu
- From:
China Cancer
2025;34(6):477-483
- CountryChina
- Language:Chinese
-
Abstract:
[Purpose]To analyze the survival rate of prostate cancer patients hospitalized in Nan-tong Tumor Hospital from 2007 to 2017.[Methods]A total of 478 prostate cancer patients were admitted in Nantong Tumor Hospital from 2007 to 2017 and 476 cases(99.58％)were followed up till December 31,2020.The survival rate of patients was analyzed with Kaplan-Meier method;Soft-ware SPSS 25.0 and the Log-rank test were employed for statistical analysis.[Results]The aver-age age of prostate cancer patients at admission was(71.74±8.02)years old,and 79.08％were aged 60～79 years.The median survival time was 43 months,and the observed 1-,3-,5-and 10-year survival rates were 77.20％,56.07％,43.01％and 24.53％,respectively.The 5-year survival rates for the age groups of 35～59,60～79 and ≥80 years old were 31.73％,46.64％and 29.65％,respectively(P＜0.05).The 5-year survival rates for patients with stage Ⅰ～Ⅱ,stage Ⅲ,stage IV,and unknown stage were 88.10％,71.66％,33.35％and 37.55％,respectively(P＜0.001).The 5-year survival rates for the periods 2007-2012 and 2013-2017 were 32.85％and 47.79％,re-spectively(P＜0.05).Furthermore survival rates differed significantly across different regions within the jurisdiction(P＜0.05).[Conclusion]Over the past decade,the survival rate of hospital-based prostate cancer patients has significantly improved.Early-stage cases can achieve better survival rates,but the survival rate of elderly patients remains a challenge.Efforts should be made to reduce the proportion of patients with unknown staging Comprehensive measures for prostate cancer prevention and control should be strengthened to reduce incidence,improve prognosis and enhance quality of life of patients.
